China Biologic Products Holdings, Inc. announced that the Company's Board of Directors has appointed Dr. Bing Li as the Chief Executive Officer of the Company, effective August 13, 2018. By assuming the CEO position, Dr. Li has moved from an independent director to an executive director of the Board. Mr. Zhijun Tong, the former acting CEO, will continue to serve as an executive director of the Board and President of the Company.

Dr. Bing Li has been a member of the Board of China Biologic since July 25, 2018 and previously served on the Board of the Company from February 2011 to May 2014. Dr. Li served as a managing director of Fosun Group.